Document is current
Any future updates will be listed below
-
Authors
Magara, Hiroshi
Tani, Takuaki
Imai, Shinobu
Kiyomi, Anna
Fushimi, Kiyohide
Sugiura, Munetoshi http://orcid.org/0000-0001-5726-0741
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (grant number: 20AA2003)
Japan Society for the Promotion of Science (grant number: 21K10299)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 5 August 2024
First Online: 13 August 2024
Declarations
:
: The study was approved by the Ethics Review Board of Tokyo University of Pharmacy and Life Science (approval number: human medical-2022-009, approval date: 25 May 2022) and conducted in accordance with Ethical Guidance for Medical and Health Research Involving Human Subjects. This study was based on a secondary analysis of claims data and did not directly involve any patients. We did not involve participants in designing the research questions, outcome measures, interpretation, or writing the results of this study. The requirement for informed consent from patients was waived because of the retrospective nature of this observational study, which analyzed de-identified data. The participants were given the opportunity to opt out via an announcement on the study website.
: Not applicable.
: Shinobu Imai, Takuaki Tani, Anna Kiyomi, Kiyohide Fushimi, and Munetoshi Sugiura have no relevant financial or non-financial interests to disclose. Hiroshi Magara is an employee of Nxera Pharma Japan Co., Ltd.
